Pareto Securities 10th Annual Health Care Conference

Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic

Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients

MedNous article: A surprise finding in the clinic

Patient insights to shape development of a dCBT for IPF patients

Untangling the dualistic components of the RAS in PF the Yin and Yang